{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:31:53Z","timestamp":1791937913217,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","award":["BASJ20220405008"],"award-info":[{"award-number":["BASJ20220405008"]}],"id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22he2302001"],"award-info":[{"award-number":["JP22he2302001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ctro.2023.100576","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T02:14:36Z","timestamp":1673057676000},"page":"100576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer"],"prefix":"10.1016","volume":"39","author":[{"given":"Yusuke","family":"Uchinami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kanehira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yokokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuki","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyasu","family":"Shido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctro.2023.100576_b0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ijrobp.2013.02.022","article-title":"Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated","volume":"86","author":"Chuong","year":"2013","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"21","key":"10.1016\/j.ctro.2023.100576_b0010","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1002\/cncr.30856","article-title":"Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review","volume":"123","author":"de Geus","year":"2017","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ctro.2023.100576_b0015","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cncr.29161","article-title":"Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma","volume":"121","author":"Herman","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2023.100576_b0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.022","article-title":"Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma","volume":"76","author":"Hoyer","year":"2005","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2023.100576_b0025","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/0284186X.2019.1631472","article-title":"Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma","volume":"58","author":"Jiang","year":"2019","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100576_b0030","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijrobp.2020.09.010","article-title":"A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer","volume":"109","author":"Witt","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2023.100576_b0035","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijrobp.2009.09.075","article-title":"A Dosimetric Model of Duodenal Toxicity After Stereotactic Body Radiotherapy for Pancreatic Cancer","volume":"78","author":"Murphy","year":"2010","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"1","key":"10.1016\/j.ctro.2023.100576_b0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2017.12.290","article-title":"Radiation Dose-Volume Effects for Liver SBRT","volume":"110","author":"Miften","year":"2021","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"2","key":"10.1016\/j.ctro.2023.100576_b0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/acm2.13165","article-title":"MRI evaluation of normal tissue deformation and breathing motion under an abdominal compression device","volume":"22","author":"Lee","year":"2021","journal-title":"J Appl Clin Med Phys"},{"issue":"8","key":"10.1016\/j.ctro.2023.100576_b0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/acm2.12681","article-title":"Impact of organ motion on volumetric and dosimetric parameters in stomach lymphomas treated with intensity-modulated radiotherapy","volume":"20","author":"Uchinami","year":"2019","journal-title":"J Appl Clin Med Phys"},{"issue":"3","key":"10.1016\/j.ctro.2023.100576_b0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.radonc.2007.12.018","article-title":"Intrafractional gastric motion and interfractional stomach deformity during radiation therapy","volume":"87","author":"Watanabe","year":"2008","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2023.100576_b0060","doi-asserted-by":"crossref","first-page":"e0205917","DOI":"10.1371\/journal.pone.0205917","article-title":"Variations of MRI-assessed peristaltic motions during radiation therapy","volume":"13","author":"Mostafaei","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ctro.2023.100576_b0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.radonc.2017.05.013","article-title":"An evaluation of motion mitigation techniques for pancreatic SBRT","volume":"124","author":"Campbell","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2023.100576_b0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2019.01.020","article-title":"Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk","volume":"134","author":"Loi","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2023.100576_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2021.08.002","article-title":"Dosimetric uncertainties resulting from interfractional anatomic variations for patients receiving pancreas stereotactic body radiation therapy and cone-beam CT image guidance","author":"Niedzielski","year":"2021","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"4","key":"10.1016\/j.ctro.2023.100576_b0080","doi-asserted-by":"crossref","first-page":"e94971","DOI":"10.1371\/journal.pone.0094971","article-title":"A proton beam therapy system dedicated to spot-scanning increases accuracy with moving tumors by real-time imaging and gating and reduces equipment size","volume":"9","author":"Shimizu","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ctro.2023.100576_b0085","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0360-3016(00)00625-8","article-title":"Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor","volume":"48","author":"Shirato","year":"2000","journal-title":"Radiation Oncology Biology"},{"issue":"3","key":"10.1016\/j.ctro.2023.100576_b0090","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/j.prro.2019.07.018","article-title":"Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)","volume":"10","author":"Oar","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2023.100576_b0095","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1177\/1533033819851520","article-title":"Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy","volume":"18","author":"Wang","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ctro.2023.100576_b0100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ctro.2022.05.004","article-title":"A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity","volume":"35","author":"Uchinami","year":"2022","journal-title":"Clinical and Translational Radiation Oncology"},{"issue":"2","key":"10.1016\/j.ctro.2023.100576_b0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.prro.2013.06.004","article-title":"Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus","volume":"4","author":"Jabbour","year":"2014","journal-title":"Pract Radiat Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2023.100576_b0110","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1080\/0284186X.2016.1221532","article-title":"Considerable pancreatic tumor motion during breath-holding","volume":"55","author":"Lens","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2023.100576_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phro.2021.12.001","article-title":"Intrafraction pancreatic tumor motion patterns during ungated magnetic resonance guided radiotherapy with an abdominal corset","volume":"21","author":"Grimbergen","year":"2022","journal-title":"Physics and Imaging in Radiation Oncology"},{"key":"10.1016\/j.ctro.2023.100576_b0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.phro.2022.02.007","article-title":"Inter- and intrafraction motion assessment and accumulated dose quantification of upper gastrointestinal organs during magnetic resonance-guided ablative radiation therapy of pancreas patients","volume":"21","author":"Alam","year":"2022","journal-title":"Physics and Imaging in Radiation Oncology"},{"issue":"4","key":"10.1016\/j.ctro.2023.100576_b0125","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijrobp.2021.02.008","article-title":"Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer","volume":"110","author":"Courtney","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2023.100576_b0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","article-title":"Stereotactic body radiotherapy for unresectable cholangiocarcinoma","volume":"94","author":"Kopek","year":"2010","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100576_b0135","doi-asserted-by":"crossref","first-page":"e13479","DOI":"10.1002\/acm2.13479","article-title":"Varian ethos online adaptive radiotherapy for prostate cancer: Early results of contouring accuracy, treatment plan quality, and treatment time","volume":"23","author":"Byrne","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ctro.2023.100576_b0140","first-page":"53","article-title":"Feasibility of ablative stereotactic body radiation therapy of pancreas cancer patients on a 1.5 Tesla magnetic resonance-linac system using abdominal compression. Physics and Imaging","volume":"19","author":"Tyagi","year":"2021","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100576_b0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.radonc.2010.02.029","article-title":"Feasibility of using intravenous contrast-enhanced computed tomography (CT) scans in lung cancer treatment planning","volume":"96","author":"Xiao","year":"2010","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100576_b0150","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.radonc.2006.09.010","article-title":"Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer","volume":"81","author":"Choi","year":"2006","journal-title":"Radiother Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630823000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:11:47Z","timestamp":1762503107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630823000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":30,"alternative-id":["S2405630823000010"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100576","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100576"}}